Beyond Conventional Analgesics: Updated Evidence Supporting Botulinum Toxin Type A for-Neuralgia Management
International Journal of Medical Sciences · 17.03.2026 · 23 (4) · 1456-1469
DOI: 10.7150/ijms.130934 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Medical Sciences, erschienen am 17.03.2026. Verfasst von Jui-Ting Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Medical Oncology, Department of Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung 43503, Taiwan. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Neuralgia, Analgesics. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Medical Oncology, Department of Medicine, Tungs' Taichung MetroHarbor Hospital, Taichung 43503, Taiwan.
- Department of Nursing, Tungs' Taichung MetroHarbor Hospital, Taichung 43503, Taiwan.
- Department of Nursing, Hungkuang University, Taichung 43304, Taiwan.
- Department of Anatomy, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
- Department of Medical Education, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
Zitieren
APA
Yu, J. T., Li, C. P., Huang, T. M., & Tsai, R. Y. (2026). Beyond Conventional Analgesics: Updated Evidence Supporting Botulinum Toxin Type A for-Neuralgia Management. International Journal of Medical Sciences, 23(4), 1456-1469. https://doi.org/10.7150/ijms.130934
Vancouver
Yu JT, Li CP, Huang TM, Tsai RY. Beyond Conventional Analgesics: Updated Evidence Supporting Botulinum Toxin Type A for-Neuralgia Management. International Journal of Medical Sciences. 2026;23(4):1456-1469. doi:10.7150/ijms.130934
BibTeX
@article{Yu2026,
author = {Yu, Jui-Ting and Li, Chen-Pi and Huang, Tsai-Mei and Tsai, Ru-Yin},
title = {Beyond Conventional Analgesics: Updated Evidence Supporting Botulinum Toxin Type A for-Neuralgia Management},
journal = {International Journal of Medical Sciences},
year = {2026},
volume = {23},
number = {4},
pages = {1456--1469},
doi = {10.7150/ijms.130934}
}
EUVIMED